GeneDx Holdings Corp.
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2019 | $-6.27 | $-7.69 |
| FY2020 | $-23,518.00 | $-14,257.32 |
| FY2021 | $-1.14 | $-9,505.32 |
| FY2022 | $-26.82 | $-7,136.17 |
| FY2023 | $-7.23 | $-5,710.43 |
| FY2024 | $-1.94 | $-4,759.01 |
| FY2025 | $-0.73 | $-4,079.26 |
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2019 | $-6.27 | $-7.69 |
| FY2020 | $-23,518.00 | $-14,257.32 |
| FY2021 | $-1.14 | $-9,505.32 |
| FY2022 | $-26.82 | $-7,136.17 |
| FY2023 | $-7.23 | $-5,710.43 |
| FY2024 | $-1.94 | $-4,759.01 |
| FY2025 | $-0.73 | $-4,079.26 |